Replication	O
of	O
type	O
1	O
human	O
immunodeficiency	O
viruses	O
containing	O
linker	O
substitution	O
mutations	O
in	O
the	O
-201	B-DNA
to	I-DNA
-130	I-DNA
region	I-DNA
of	O
the	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
.	O

In	O
previous	O
transfection	O
analyses	O
using	O
the	O
chloramphenicol	B-protein
acetyltransferase	I-protein
reporter	B-DNA
gene	I-DNA
system	O
,	O
we	O
determined	O
that	O
linker	O
substitution	O
(	O
LS	O
)	O
mutations	O
between	O
-201	B-DNA
and	I-DNA
-130	I-DNA
(	O
relative	O
to	O
the	O
transcription	O
start	O
site	O
)	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
caused	O
moderate	O
decreases	O
in	O
LTR	B-DNA
transcriptional	O
activity	O
in	O
a	O
T-cell	B-cell_line
line	I-cell_line
(	O
S.L.Zeichner	O
,	O
J.Y.H.	O
Kim	O
,	O
and	O
J.C.Alwine	O
,	O
J.Virol.65	O
:	O
2436-2444	O
,	O
1991	O
)	O
.	O

In	O
order	O
to	O
confirm	O
the	O
significance	O
of	O
this	O
region	O
in	O
the	O
context	O
of	O
viral	O
replication	O
,	O
we	O
constructed	O
several	O
of	O
these	O
LS	O
mutations	O
(	O
-201	B-DNA
to	I-DNA
-	I-DNA
184	I-DNA
,	O
-183	B-DNA
to	I-DNA
-166	I-DNA
,	O
-165	B-DNA
to	I-DNA
-148	I-DNA
,	O
and	O
-148	B-DNA
to	I-DNA
-130	I-DNA
)	O
in	O
proviruses	O
and	O
prepared	O
viral	O
stocks	O
by	O
cocultivation	O
of	O
transfected	B-cell_line
RD	I-cell_line
cells	I-cell_line
with	O
CEMx174	B-cell_line
cells	I-cell_line
.	O

In	O
addition	O
,	O
two	O
mutations	O
between	O
-93	B-DNA
and	I-DNA
-76	I-DNA
and	O
between	O
-75	B-DNA
and	I-DNA
-58	I-DNA
were	O
utilized	O
,	O
since	O
they	O
affect	O
the	O
nuclear	B-DNA
factor	I-DNA
kappa	I-DNA
B	I-DNA
(	I-DNA
NF-kappa	I-DNA
B	I-DNA
)	I-DNA
-	I-DNA
and	I-DNA
Sp1-binding	I-DNA
sites	I-DNA
and	O
were	O
expected	O
to	O
diminish	O
viral	O
replication	O
.	O

Our	O
results	O
suggest	O
that	O
while	O
transfection	O
analyses	O
offer	O
an	O
adequate	O
approximation	O
of	O
the	O
effects	O
of	O
the	O
LS	O
mutations	O
,	O
the	O
analysis	O
of	O
viral	O
replication	O
using	O
a	O
mutant	O
viral	O
stock	O
presents	O
a	O
more	O
accurate	O
picture	O
,	O
which	O
is	O
sometimes	O
at	O
variance	O
with	O
the	O
transfection	O
results	O
.	O

Three	O
mutants	O
(	O
-201/-184	O
NXS	O
,	O
-165/-148	O
NXS	O
,	O
and	O
-147/-130	O
NXS	O
)	O
had	O
effects	O
on	O
viral	O
replication	O
that	O
were	O
much	O
more	O
severe	O
than	O
the	O
effects	O
predicted	O
from	O
their	O
performance	O
in	O
transfection	O
analyses	O
,	O
and	O
the	O
effects	O
of	O
two	O
LS	O
mutations	O
(	O
-201/-184	O
NXS	O
and	O
-183/-166	O
NXS	O
)	O
were	O
not	O
predicted	O
by	O
their	O
effects	O
in	O
transfection	O
.	O

In	O
addition	O
,	O
we	O
observed	O
cell	O
type-specific	O
permissiveness	O
to	O
replication	O
of	O
some	O
mutant	O
viruses	O
.	O

In	O
the	O
cell	O
types	O
tested	O
,	O
the	O
LS	O
mutations	O
indicated	O
an	O
apparent	O
requirement	O
not	O
only	O
for	O
the	O
intact	O
NF-kappa	B-protein
B	I-protein
and	O
SP1-binding	B-DNA
sites	I-DNA
but	O
also	O
for	O
several	O
regions	O
between	O
-201	B-DNA
and	I-DNA
-130	I-DNA
not	O
previously	O
associated	O
with	O
viral	O
infectivity	O
.	O

JOURNAL	NULL
oF	NULL
VirOLOGY	NULL
,	NULL
Mar	NULL
.	NULL

1993	NULL
,	NULL
p.	NULL
1658-1662	NULL
0022-538	NULL
X	NULL
,	NULL
/93/031658-05	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

67	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Replication	NULL
of	NULL
Type	NULL
1	NULL
Human	NULL
Immunodeficiency	NULL
Viruses	NULL
Containing	NULL
Linker	NULL
Substitution	NULL
Mutations	NULL
in	NULL
the	NULL
-201	NULL
to	NULL
-130	NULL
Region	NULL
of	NULL
the	NULL
Long	NULL
Terminal	NULL
Repeat	NULL
JOHN	NULL
Y.	NULL
H.	NULL
KIM	NULL
,	NULL
``	NULL
FRANCISCO	NULL
GONZALEZ-SCARANO	NULL
,	NULL
***	NULL
STEVEN	NULL
L.	NULL
ZEICHNER	NULL
,	NULL
*t	NULL
AND	NULL
JAMES	NULL
C.	NULL
ALWINE®	NULL
Departments	NULL
of	NULL
Neurology	NULL
and	NULL
Microbiology	NULL
and	NULL
Graduate	NULL
Group	NULL
in	NULL
Neurosciences	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Pennsylvania	NULL
Medical	NULL
Center	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19104-6146	NULL
Received	NULL
9	NULL
September	NULL
1992/Accepted	NULL
1	NULL
December	NULL
1992	NULL
In	NULL
previous	NULL
transfection	NULL
analyses	NULL
using	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
system	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
linker	NULL
substitution	NULL
(	NULL
LS	NULL
)	NULL
mutations	NULL
between	NULL
-201	NULL
and	NULL
-130	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
caused	NULL
moderate	NULL
decreases	NULL
in	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
(	NULL
S.	NULL
L.	NULL
Zeichner	NULL
,	NULL
J.	NULL
Y.	NULL
H.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
,	NULL
J.	NULL
Virol	NULL
.	NULL

65:2436-2444	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
the	NULL
significance	NULL
of	NULL
this	NULL
region	NULL
in	NULL
the	NULL
context	NULL
of	NULL
viral	NULL
replication	NULL
,	NULL
we	NULL
constructed	NULL
several	NULL
of	NULL
these	NULL
LS	NULL
mutations	NULL
(	NULL
-201	NULL
to	NULL
-184	NULL
,	NULL
-183	NULL
to	NULL
-166	NULL
,	NULL
-165	NULL
to	NULL
-148	NULL
,	NULL
and	NULL
-148	NULL
to	NULL
-130	NULL
)	NULL
in	NULL
proviruses	NULL
and	NULL
prepared	NULL
viral	NULL
stocks	NULL
by	NULL
cocultivation	NULL
of	NULL
transfected	NULL
RD	NULL
cells	NULL
with	NULL
CEMx174	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
mutations	NULL
between	NULL
-93	NULL
and	NULL
-76	NULL
and	NULL
between	NULL
-75	NULL
and	NULL
-58	NULL
were	NULL
utilized	NULL
,	NULL
since	NULL
they	NULL
affect	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
and	NULL
were	NULL
expected	NULL
to	NULL
diminish	NULL
viral	NULL
replication	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
while	NULL
transfection	NULL
analyses	NULL
offer	NULL
an	NULL
adequate	NULL
approximation	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
LS	NULL
mutations	NULL
,	NULL
the	NULL
analysis	NULL
of	NULL
viral	NULL
replication	NULL
using	NULL
a	NULL
mutant	NULL
viral	NULL
stock	NULL
presents	NULL
a	NULL
more	NULL
accurate	NULL
picture	NULL
,	NULL
which	NULL
is	NULL
sometimes	NULL
at	NULL
variance	NULL
with	NULL
the	NULL
transfection	NULL
results	NULL
.	NULL

Three	NULL
mutants	NULL
(	NULL
-201/-184	NULL
NXS	NULL
,	NULL
-165/-148	NULL
NXS	NULL
,	NULL
and	NULL
-147/-130	NULL
NXS	NULL
)	NULL
had	NULL
effects	NULL
on	NULL
viral	NULL
replication	NULL
that	NULL
were	NULL
much	NULL
more	NULL
severe	NULL
than	NULL
the	NULL
effects	NULL
predicted	NULL
from	NULL
their	NULL
performance	NULL
in	NULL
transfection	NULL
analyses	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
two	NULL
LS	NULL
mutations	NULL
(	NULL
-201/-184	NULL
NXS	NULL
and	NULL
-183/-166	NULL
NXS	NULL
)	NULL
were	NULL
not	NULL
predicted	NULL
by	NULL
their	NULL
effects	NULL
in	NULL
transfection	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
observed	NULL
cell	NULL
type-specific	NULL
permissiveness	NULL
to	NULL
replication	NULL
of	NULL
some	NULL
mutant	NULL
viruses	NULL
.	NULL

In	NULL
the	NULL
cell	NULL
types	NULL
tested	NULL
,	NULL
the	NULL
LS	NULL
mutations	NULL
indicated	NULL
an	NULL
apparent	NULL
requirement	NULL
not	NULL
only	NULL
for	NULL
the	NULL
intact	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
SP1-binding	NULL
sites	NULL
but	NULL
also	NULL
for	NULL
several	NULL
regions	NULL
between	NULL
-201	NULL
and	NULL
-130	NULL
not	NULL
previously	NULL
associated	NULL
with	NULL
viral	NULL
infectivity	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
analyzed	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV-1	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
with	NULL
a	NULL
set	NULL
of	NULL
linker	NULL
substitution	NULL
mutants	NULL
spanning	NULL
the	NULL
entire	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
(	NULL
HXB2	NULL
)	NULL
LTR	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

These	NULL
discrete	NULL
mutations	NULL
preserve	NULL
the	NULL
spatial	NULL
relationships	NULL
of	NULL
the	NULL
adjacent	NULL
wild-type	NULL
LTR	NULL
sequences	NULL
.	NULL

In	NULL
transient	NULL
transfection	NULL
experiments	NULL
with	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
system	NULL
(	NULL
LTR-CAT	NULL
construct	NULL
)	NULL
,	NULL
we	NULL
established	NULL
that	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
LTR	NULL
involves	NULL
previously	NULL
uncharacterized	NULL
U3	NULL
regions	NULL
and	NULL
that	NULL
the	NULL
functional	NULL
utility	NULL
of	NULL
certain	NULL
LTR	NULL
regions	NULL
is	NULL
cell	NULL
type	NULL
dependent	NULL
and	NULL
can	NULL
vary	NULL
with	NULL
cellular	NULL
stimulation	NULL
or	NULL
differentiation	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
extended	NULL
these	NULL
studies	NULL
by	NULL
introducing	NULL
a	NULL
selected	NULL
sample	NULL
of	NULL
these	NULL
mutant	NULL
LTRs	NULL
into	NULL
proviral	NULL
constructs	NULL
and	NULL
analyzing	NULL
their	NULL
effects	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
.	NULL

Generation	NULL
of	NULL
wild-type	NULL
and	NULL
linker	NULL
substitution	NULL
mutant	NULL
LTR	NULL
HIV-1	NULL
stocks	NULL
.	NULL

Linker	NULL
substitution	NULL
mutations	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
were	NULL
prepared	NULL
previously	NULL
by	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
technology	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Each	NULL
mutant	NULL
contains	NULL
a	NULL
substitution	NULL
of	NULL
18	NULL
bp	NULL
of	NULL
wild-type	NULL
HIV-1	NULL
(	NULL
HXB2	NULL
)	NULL
LTR	NULL
sequence	NULL
with	NULL
an	NULL
NdeI-Xhol-Sall	NULL
(	NULL
NXS	NULL
)	NULL
polylinker	NULL
(	NULL
5	NULL
!	NULL

-CATATGCTCG	NULL
AGGTCGAC-3	NULL
'	NULL
)	NULL
.	NULL

Mutants	NULL
were	NULL
labelled	NULL
according	NULL
to	NULL
the	NULL
n/m	NULL
NXS	NULL
nomenclature	NULL
,	NULL
with	NULL
n	NULL
and	NULL
m	NULL
referring	NULL
to	NULL
the	NULL
positions	NULL
of	NULL
LTR	NULL
nucleotides	NULL
substituted	NULL
by	NULL
the	NULL
5'-	NULL
and	NULL
3'-terminal	NULL
nucleotides	NULL
of	NULL
the	NULL
NXS	NULL
polylinker	NULL
,	NULL
respectively	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
Pediatrics	NULL
Branch	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

1658	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

We	NULL
selected	NULL
six	NULL
mutant	NULL
LTRs	NULL
for	NULL
further	NULL
study	NULL
.	NULL

Four	NULL
linker	NULL
substitution	NULL
mutants	NULL
,	NULL
which	NULL
together	NULL
span	NULL
nucleotides	NULL
-201	NULL
to	NULL
-130	NULL
,	NULL
altered	NULL
certain	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
and	NULL
,	NULL
in	NULL
LTR-CAT	NULL
transfection	NULL
studies	NULL
,	NULL
displayed	NULL
between	NULL
25	NULL
and	NULL
70	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
CAT	NULL
activity	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
mutants	NULL
-147/-130	NULL
NXS	NULL
,	NULL
-165/-148	NULL
NXS	NULL
,	NULL
-183/-166	NULL
NXS	NULL
,	NULL
and	NULL
-201/-184	NULL
NXS	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
mutants	NULL
,	NULL
-75/-58	NULL
NXS	NULL
and	NULL
-93/-76	NULL
NXS	NULL
,	NULL
which	NULL
affect	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
(	NULL
NF-kB	NULL
)	NULL
-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
,	NULL
were	NULL
selected	NULL
as	NULL
controls	NULL
,	NULL
since	NULL
they	NULL
dramatically	NULL
decreased	NULL
LTR-mediated	NULL
transcription	NULL
and	NULL
were	NULL
expected	NULL
to	NULL
demonstrate	NULL
the	NULL
most	NULL
significant	NULL
effects	NULL
on	NULL
replication	NULL
with	NULL
mutant	NULL
viruses	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mutated	NULL
LTR	NULL
regions	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
were	NULL
-75	NULL
to	NULL
-58	NULL
,	NULL
-93	NULL
to	NULL
-76	NULL
,	NULL
-147	NULL
to	NULL
-130	NULL
,	NULL
-165	NULL
to	NULL
-148	NULL
,	NULL
-183	NULL
to	NULL
-166	NULL
,	NULL
and	NULL
-201	NULL
to	NULL
-184	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Each	NULL
NXS	NULL
linker	NULL
substitution	NULL
LTR	NULL
was	NULL
cloned	NULL
into	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
single	NULL
LTR	NULL
and	NULL
complete	NULL
proviral	NULL
coding	NULL
sequences	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
single-LTR	NULL
proviral	NULL
fragment	NULL
was	NULL
obtained	NULL
by	NULL
BamHI	NULL
digestion	NULL
of	NULL
pILIC	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
E.	NULL
Vicenzi	NULL
,	NULL
M.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
Rabson	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
complete	NULL
viral	NULL
coding	NULL
sequences	NULL
originally	NULL
derived	NULL
from	NULL
the	NULL
infectious	NULL
molecular	NULL
clone	NULL
of	NULL
HIV-1	NULL
(	NULL
pNL4-3	NULL
)	NULL
(	NULL
10	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

To	NULL
avoid	NULL
the	NULL
possible	NULL
complicating	NULL
effects	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
3	NULL
'	NULL
LTR	NULL
on	NULL
nef	NULL
function	NULL
,	NULL
we	NULL
inserted	NULL
an	NULL
Xbal	NULL
linker	NULL
(	NULL
Stratagene	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
stop	NULL
codons	NULL
,	NULL
into	NULL
the	NULL
nef-coding	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
,	NULL
pG3-ILICX	NULL
,	NULL
was	NULL
also	NULL
employed	NULL
in	NULL
subcloning	NULL
each	NULL
single-LTR	NULL
proviral	NULL
NXS	NULL
mutant	NULL
as	NULL
well	NULL
as	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
U	NULL
I	NULL
I	NULL
I	NULL
J	NULL
I	NULL
I	NULL
I	NULL
U	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
500	NULL
~400	NULL
+300	NULL
200	NULL
100	NULL
+1	NULL
+100	NULL
m	NULL
A	NULL
Gn	NULL
ﬂ	NULL
m	NULL
AA	NULL
AP1	NULL
URS	NULL
sP1	NULL
Tal	NULL
tar	NULL
TCF-1a	NULL
m-	NULL
'	NULL
n	NULL
M	NULL
[	NULL
-A	NULL
NFAT	NULL
USF1	NULL
NFKB	NULL
LBPUBP	NULL
Xba	NULL
I	NULL
~Hrg	NULL
-~	NULL
)	NULL
Hind	NULL
IN	NULL
--	NULL
-	NULL
#	NULL
--	NULL
®	NULL
T	NULL
--	NULL
NXS	NULL
MUTANTS	NULL
/	NULL
\	NULL
erovisat	NULL
utr	NULL
&	NULL
8	NULL
$	NULL
&	NULL
f	NULL
g	NULL
0	NULL
R	NULL
os	NULL
(	NULL
1.00	NULL
)	NULL
URS	NULL
-	NULL
usF1	NULL
TCF-ia	NULL
NFkB	NULL
NFkB	NULL
-	NULL
SP1	NULL
SP1	NULL
SP1	NULL
U	NULL
I	NULL
H	NULL
K	NULL
1	NULL
(	NULL
0.21	NULL
)	NULL
(	NULL
0.04	NULL
)	NULL
(	NULL
0.25	NULL
)	NULL
greseremies	NULL
.	NULL

|	NULL
--	NULL
]	NULL
RBB	NULL
}	NULL
--	NULL
-LT-	NULL
}	NULL
|	NULL
--	NULL
|	NULL
(	NULL
0.46	NULL
)	NULL
crssereaes	NULL
.	NULL

BRB	NULL
T	NULL
-J	NULL
--	NULL
-	NULL
LCT-	NULL
}	NULL
-	NULL
(	NULL
0.42	NULL
)	NULL
|	NULL
L	NULL
ff	NULL
1T	NULL
TJC	NULL
(	NULL
0.69	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Map	NULL
of	NULL
HIV-1	NULL
LTR	NULL
DNA	NULL
showing	NULL
the	NULL
relative	NULL
positions	NULL
of	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
and	NULL
linker	NULL
substitution	NULL
mutations	NULL
(	NULL
3	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
values	NULL
on	NULL
the	NULL
left	NULL
represent	NULL
averages	NULL
relative	NULL
to	NULL
wild-type	NULL
LTR	NULL
activity	NULL
from	NULL
multiple	NULL
transient	NULL
transfections	NULL
of	NULL
phytohemagglutinin-	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
see	NULL
text	NULL
and	NULL
reference	NULL
23	NULL
)	NULL
.	NULL

In	NULL
the	NULL
expanded	NULL
diagrams	NULL
of	NULL
the	NULL
mutants	NULL
,	NULL
open	NULL
boxes	NULL
represent	NULL
wild-type	NULL
sequences	NULL
and	NULL
filled	NULL
boxes	NULL
represent	NULL
NXS	NULL
linker	NULL
substitutions	NULL
.	NULL

Abbreviations	NULL
:	NULL
AP1	NULL
,	NULL
activator	NULL
protein	NULL
1	NULL
;	NULL
IL2/IL2R	NULL
,	NULL
interleukin-2-interleukin-2	NULL
receptor	NULL
promoter	NULL
;	NULL
TA	NULL
,	NULL
TATA	NULL
element	NULL
;	NULL
I	NULL
,	NULL
initiator	NULL
element	NULL
;	NULL
TAR	NULL
,	NULL
trans-acting	NULL
responsive	NULL
element	NULL
;	NULL
LBP/UBP	NULL
,	NULL
leader	NULL
or	NULL
untranslated	NULL
binding	NULL
protein	NULL
.	NULL

Nucleotide	NULL
positions	NULL
are	NULL
numbered	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

equivalent	NULL
wild-type	NULL
sequences	NULL
from	NULL
HXB2	NULL
,	NULL
the	NULL
parent	NULL
HIV	NULL
strain	NULL
used	NULL
for	NULL
construction	NULL
of	NULL
the	NULL
NXS	NULL
linker	NULL
substitution	NULL
mutants	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
Xbal-SphI	NULL
LTR-containing	NULL
fragment	NULL
of	NULL
pG3-ILICX	NULL
was	NULL
ligated	NULL
into	NULL
pGEM3Zf	NULL
(	NULL
-	NULL
)	NULL
with	NULL
its	NULL
HindIII	NULL
site	NULL
deleted	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
insert	NULL
was	NULL
digested	NULL
with	NULL
XbaI	NULL
and	NULL
HindIII	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
wild-type	NULL
LTR	NULL
fragment	NULL
was	NULL
replaced	NULL
by	NULL
each	NULL
Xbal-HindIII	NULL
NXS	NULL
mutant	NULL
LTR	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Each	NULL
resulting	NULL
mutant	NULL
pG3H	NULL
n/m	NULL
NXS	NULL
clone	NULL
was	NULL
digested	NULL
with	NULL
Xbal	NULL
and	NULL
SphI	NULL
to	NULL
release	NULL
complete	NULL
mutant	NULL
LTR	NULL
inserts	NULL
(	NULL
Fig	NULL
.	NULL

2E	NULL
)	NULL
for	NULL
replacement	NULL
of	NULL
the	NULL
LTR	NULL
of	NULL
pG3-ILICX	NULL
to	NULL
construct	NULL
a	NULL
panel	NULL
of	NULL
circularly	NULL
permuted	NULL
proviral	NULL
clones	NULL
,	NULL
each	NULL
with	NULL
a	NULL
single	NULL
mutant	NULL
LTR	NULL
,	NULL
called	NULL
pG3I	NULL
n/m	NULL
NXS	NULL
or	NULL
pG3IWT	NULL
(	NULL
Fig	NULL
.	NULL

2F	NULL
)	NULL
.	NULL

Mutant	NULL
and	NULL
wild-type	NULL
HIV-1	NULL
infectious	NULL
DNAs	NULL
were	NULL
generated	NULL
as	NULL
concatemers	NULL
of	NULL
the	NULL
single-LTR-containing	NULL
proviral	NULL
fragment	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Fig	NULL
.	NULL

2G	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Concate-merized	NULL
proviral	NULL
DNA	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
RD	NULL
cell	NULL
line	NULL
,	NULL
a	NULL
CD4-negative	NULL
rhabdomyosarcoma-derived	NULL
human	NULL
cell	NULL
line	NULL
(	NULL
18	NULL
)	NULL
,	NULL
by	NULL
using	NULL
Lipofectin	NULL
(	NULL
25	NULL
ug	NULL
)	NULL
in	NULL
Opti-MEM	NULL
(	NULL
both	NULL
NOTES	NULL
1659	NULL
BameI	NULL
-	NULL
Hibd	NULL
!	NULL

ll	NULL
-	NULL
gingiip	NULL
|	NULL
HingiH	NULL
BamHI	NULL
A	NULL
)	NULL
-	NULL
plLic	NULL
Xhot	NULL
Sphi	NULL
Hinditt	NULL
C	NULL
H	NULL
H	NULL
H	NULL
e	NULL
By	NULL
_	NULL
pGB-AILICX	NULL
Hj—rﬁA—g—r	NULL
‘	NULL
l	NULL
Xbal	NULL
s	NULL
H	NULL
H	NULL
C	NULL
)	NULL
pGBH-LTR	NULL
Xbal	NULL
s	NULL
H	NULL
D	NULL
)	NULL
_	NULL
pG3H-LTR	NULL
|..|	NULL
:	NULL
[	NULL
I	NULL
Xbal-Hind1|\	NULL
Xbal	NULL
E	NULL
)	NULL
_	NULL
pG3H	NULL
(	NULL
mm	NULL
)	NULL
NXS	NULL
Xbal	NULL
S	NULL
8	NULL
H	NULL
H	NULL
h	NULL
8	NULL
F	NULL
)	NULL
_	NULL
pGsi	NULL
(	NULL
mm	NULL
)	NULL
Nxs	NULL
FrﬂbﬁJWA—lﬁ—i	NULL
Xbal	NULL
s	NULL
H	NULL
BamH	NULL
H	NULL
h	NULL
h	NULL
BamHI	NULL
-	NULL
H	NULL
G	NULL
)	NULL
pG3I	NULL
(	NULL
n/m	NULL
)	NULL
NXS~—J—rEIb——'—	NULL
‘	NULL
—V	NULL
gﬂsemers	NULL
Xbal	NULL
§	NULL
H	NULL
xbal	NULL
h	NULL
|	NULL
A	NULL
|	NULL
|	NULL
|	NULL
1	NULL
|	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
1	NULL
ko	NULL
-	NULL
0.0	NULL
z.ov	NULL
6.0	NULL
8.0	NULL
9.7	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Construction	NULL
of	NULL
linker	NULL
substitution	NULL
mutant	NULL
LTR-containing	NULL
proviruses	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
NL4-3	NULL
proviral	NULL
fragment	NULL
with	NULL
a	NULL
single	NULL
LTR	NULL
(	NULL
open	NULL
rectangle	NULL
)	NULL
and	NULL
an	NULL
intact	NULL
Xhol	NULL
site	NULL
was	NULL
obtained	NULL
by	NULL
BamHI	NULL
digestion	NULL
of	NULL
pILIC	NULL
(	NULL
A	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

pG3-ILICX	NULL
(	NULL
B	NULL
)	NULL
,	NULL
containing	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
Xhol	NULL
site	NULL
produced	NULL
by	NULL
insertion	NULL
of	NULL
an	NULL
Xbal	NULL
linker	NULL
containing	NULL
stop	NULL
codons	NULL
in	NULL
each	NULL
reading	NULL
frame	NULL
of	NULL
nef	NULL
,	NULL
was	NULL
digested	NULL
to	NULL
release	NULL
the	NULL
Xbal-SphI	NULL
LTR-containing	NULL
fragment	NULL
,	NULL
which	NULL
was	NULL
cloned	NULL
into	NULL
pG3H-LTR	NULL
(	NULL
C	NULL
)	NULL
for	NULL
exchange	NULL
of	NULL
LTRs	NULL
.	NULL

The	NULL
Xbal-HindIII	NULL
LTR	NULL
fragment	NULL
from	NULL
linker	NULL
substitution	NULL
mutant	NULL
plasmids	NULL
,	NULL
containing	NULL
the	NULL
NXS	NULL
linker	NULL
(	NULL
filled	NULL
box	NULL
)	NULL
,	NULL
replaced	NULL
corresponding	NULL
wild-type	NULL
LTR	NULL
sequences	NULL
in	NULL
pG3H-LTR	NULL
(	NULL
D	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
pG3H	NULL
n/m	NULL
NXS	NULL
series	NULL
(	NULL
E	NULL
)	NULL
.	NULL

The	NULL
Xbal-SphI	NULL
fragment	NULL
of	NULL
pG3H	NULL
n/m	NULL
NXS	NULL
replaced	NULL
the	NULL
wild-type	NULL
LTR	NULL
fragment	NULL
in	NULL
pG3-ILICX	NULL
to	NULL
generate	NULL
the	NULL
pG3l	NULL
n/m	NULL
NXS	NULL
series	NULL
(	NULL
F	NULL
)	NULL
.	NULL

For	NULL
transfection-cocultivation	NULL
experiments	NULL
,	NULL
concatemers	NULL
of	NULL
BamHI	NULL
proviral	NULL
fragments	NULL
of	NULL
pG3I	NULL
n/m	NULL
NXS	NULL
and	NULL
pG3-ILICX	NULL
(	NULL
pG3IWT	NULL
[	NULL
wild	NULL
type	NULL
)	NULL
)	NULL
were	NULL
generated	NULL
,	NULL
restoring	NULL
LTRs	NULL
to	NULL
appropriate	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
positions	NULL
relative	NULL
to	NULL
NL4-3	NULL
coding	NULL
sequences	NULL
(	NULL
G	NULL
)	NULL
.	NULL

A	NULL
kilobase	NULL
scale	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Abbreviations	NULL
:	NULL
B	NULL
,	NULL
BamHI	NULL
;	NULL
H	NULL
,	NULL
HindIII	NULL
;	NULL
S	NULL
,	NULL
SphI	NULL
.	NULL

from	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

Within	NULL
48	NULL
to	NULL
72	NULL
h	NULL
,	NULL
the	NULL
transfected	NULL
RD	NULL
cultures	NULL
were	NULL
cocultivated	NULL
with	NULL
10°	NULL
CEMx174	NULL
cells	NULL
(	NULL
a	NULL
T-cell-B-cell	NULL
hybrid	NULL
[	NULL
7	NULL
,	NULL
17	NULL
]	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
to	NULL
72	NULL
h.	NULL
Infected	NULL
CEMx174	NULL
cultures	NULL
were	NULL
then	NULL
expanded	NULL
for	NULL
4	NULL
to	NULL
23	NULL
days	NULL
.	NULL

This	NULL
approach	NULL
proved	NULL
to	NULL
be	NULL
efficient	NULL
for	NULL
generating	NULL
mutant	NULL
virus	NULL
stocks	NULL
,	NULL
and	NULL
under	NULL
cocultivation	NULL
conditions	NULL
all	NULL
six	NULL
mutant	NULL
viruses	NULL
were	NULL
able	NULL
to	NULL
replicate	NULL
to	NULL
levels	NULL
resulting	NULL
in	NULL
detectable	NULL
cytopathic	NULL
effects	NULL
(	NULL
CPE	NULL
)	NULL
,	NULL
primarily	NULL
syncytium	NULL
formation	NULL
.	NULL

To	NULL
avoid	NULL
degradation	NULL
of	NULL
viral	NULL
infectivity	NULL
due	NULL
to	NULL
prolonged	NULL
cocultivation	NULL
,	NULL
the	NULL
more	NULL
rapidly	NULL
replicating	NULL
viruses	NULL
were	NULL
harvested	NULL
earlier	NULL
than	NULL
those	NULL
with	NULL
lower	NULL
levels	NULL
of	NULL
cytopathic	NULL
effect	NULL
.	NULL

After	NULL
the	NULL
viruses	NULL
were	NULL
harvested	NULL
,	NULL
virus	NULL
stock	NULL
titers	NULL
were	NULL
standardized	NULL
by	NULL
measuring	NULL
p24®°*	NULL
concentrations	NULL
with	NULL
an	NULL
antigen	NULL
capture	NULL
assay	NULL
(	NULL
sensi-	NULL
1660	NULL
NOTES	NULL
A	NULL
5	NULL
10	NULL
PBL	NULL
_	NULL
]	NULL
106	NULL
-	NULL
©	NULL
NL4-3	NULL
(	NULL
wt	NULL
)	NULL
@	NULL
7558	NULL
NXS	NULL
w-	NULL
V	NULL
-ss-7e	NULL
NXs	NULL
E	NULL
10°	NULL
-	NULL
w	NULL
-147/130	NULL
NXS	NULL
@	NULL
[	NULL
]	NULL
xs	NULL
&	NULL
I	NULL
183-166	NULL
NXs	NULL
=	NULL
10°	NULL
-	NULL
A	NULL
201/184	NULL
NXS	NULL
0-0	NULL
g	NULL
10°	NULL
0	NULL
8	NULL
l\2\ﬁ	NULL
$	NULL
/	NULL
Sg	NULL
m	NULL
ao	NULL
-	NULL
|_|	NULL
£	NULL
jo	NULL
/	NULL
&	NULL
.6	NULL
l/	NULL
m	NULL
/	NULL
102	NULL
g	NULL
``	NULL
!	NULL

ii§'=—l—=	NULL
'	NULL
S§f=	NULL
--	NULL
B	NULL
10-8	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
so	NULL
Days	NULL
after	NULL
infection	NULL
C	NULL
10°	NULL
CEMx174	NULL
»	NULL
A	NULL
/	NULL
\8	NULL
>	NULL
-—gqa	NULL
€	NULL
B4	NULL
£	NULL
O	NULL
10°	NULL
-	NULL
.	NULL

C	NULL
O	NULL
NL4-3	NULL
(	NULL
wi	NULL
)	NULL
§	NULL
@	NULL
nxs	NULL
€	NULL
0	NULL
-	NULL
V	NULL
«	NULL
ssr7e	NULL
Nxs	NULL
g	NULL
¥	NULL
W	NULL
147/130	NULL
NXS	NULL
g	NULL
C	NULL
~1sse48	NULL
Ns	NULL
m	NULL
ag	NULL
-	NULL
A	NULL
[	NULL
m	NULL
]	NULL
N	NULL
83-86	NULL
NXS	NULL
<	NULL
A	NULL
«	NULL
2012184	NULL
NXS	NULL
st	NULL
pA	NULL
a	NULL
¥	NULL
C	NULL
.	NULL

%	NULL
E_'74	NULL
‘	NULL
3/	NULL
v	NULL
ye	NULL
w/'\	NULL
/	NULL
10	NULL
%	NULL
isi\	NULL
U¥	NULL
--	NULL
--	NULL
*	NULL
10°	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
Days	NULL
after	NULL
infection	NULL
tivity	NULL
,	NULL
10	NULL
to	NULL
20	NULL
pg/ml	NULL
)	NULL
and	NULL
confirmed	NULL
by	NULL
determining	NULL
the	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
of	NULL
virus	NULL
pellets	NULL
.	NULL

All	NULL
virus	NULL
stocks	NULL
contained	NULL
significant	NULL
amounts	NULL
of	NULL
both	NULL
,	NULL
with	NULL
similar	NULL
reverse	NULL
transcriptase-to-p24	NULL
``	NULL
*	NULL
ratios	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
titers	NULL
of	NULL
some	NULL
mutant	NULL
viruses	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
attain	NULL
a	NULL
maximum	NULL
equivalent	NULL
inoculum	NULL
in	NULL
subsequent	NULL
individual-cell-type	NULL
infections	NULL
of	NULL
approximately	NULL
15	NULL
ng	NULL
of	NULL
p24°	NULL
``	NULL
~	NULL
per	NULL
ml	NULL
.	NULL

This	NULL
amount	NULL
of	NULL
p24°	NULL
``	NULL
®	NULL
resulted	NULL
in	NULL
an	NULL
infectivity	NULL
of	NULL
wild-type	NULL
HIV-1	NULL
stocks	NULL
in	NULL
CEMx174	NULL
cells	NULL
of	NULL
10°	NULL
to	NULL
10°	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infective	NULL
doses	NULL
per	NULL
ml	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.1	NULL
to	NULL
0.5	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infective	NULL
dose	NULL
per	NULL
cell	NULL
.	NULL

Infections	NULL
demonstrate	NULL
cell	NULL
type-specific	NULL
permissiveness	NULL
.	NULL

Equivalent	NULL
inocula	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
virus	NULL
stocks	NULL
were	NULL
used	NULL
to	NULL
infect	NULL
individual	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
the	NULL
production	NULL
of	NULL
viral	NULL
antigen	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
quantified	NULL
by	NULL
the	NULL
level	NULL
of	NULL
p24°°®	NULL
antigen	NULL
.	NULL

The	NULL
results	NULL
were	NULL
reproducible	NULL
among	NULL
separate	NULL
infections	NULL
;	NULL
typical	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Stimulated	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
and	NULL
11.8	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
supported	NULL
the	NULL
replication	NULL
of	NULL
only	NULL
wild-type	NULL
and	NULL
mutant	NULL
-183/-166	NULL
NXS	NULL
viruses	NULL
.	NULL

Wild-type	NULL
HIV-1	NULL
achieved	NULL
peak	NULL
p24®°®	NULL
levels	NULL
of	NULL
approximately	NULL
10°	NULL
ng/ml	NULL
10	NULL
days	NULL
J.	NULL
Viror	NULL
.	NULL

10°	NULL
106	NULL
=	NULL
O	NULL
E	NULL
19	NULL
4	NULL
2	NULL
_.	NULL
go	NULL
1¢	NULL
a	NULL
O	NULL
$	NULL
80	NULL
ao	NULL
#	NULL
0	NULL
``	NULL
G	NULL
lan	NULL
©	NULL
NL43	NULL
(	NULL
wi	NULL
)	NULL
a	NULL
@	NULL
7558	NULL
Nxs	NULL
@	NULL
ay	NULL
-	NULL
y	NULL
sare	NULL
xs	NULL
<	NULL
O	NULL
¥	NULL
147/130	NULL
Nxs	NULL
<	NULL
O/	NULL
[	NULL
G	NULL
16548	NULL
NXs	NULL
C	NULL
3	NULL
gon	NULL
-	NULL
I	NULL
183166	NULL
NXS	NULL
l	NULL
O	NULL
/	NULL
:	NULL
/A	NULL
2016184	NULL
NXS	NULL
a	NULL
‘	NULL
J	NULL
f._	NULL
!	NULL

,	NULL
¢	NULL
-	NULL
WJ	NULL
.\i	NULL
&	NULL
104	NULL
I	NULL
I	NULL
I	NULL
``	NULL
T	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
so	NULL
Days	NULL
after	NULL
infection	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Replication	NULL
of	NULL
wild-type	NULL
HIV-1	NULL
and	NULL
NXS	NULL
linker	NULL
substitution	NULL
mutant	NULL
HIV-1	NULL
viruses	NULL
in	NULL
human	NULL
PBL	NULL
s	NULL
and	NULL
T-cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
infected	NULL
in	NULL
duplicate	NULL
with	NULL
viral	NULL
inocula	NULL
containing	NULL
5	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
*H-reverse	NULL
transcriptase	NULL
activity	NULL
(	NULL
approximately	NULL
15	NULL
ng	NULL
of	NULL
p24	NULL
``	NULL
of	NULL
each	NULL
virus	NULL
stock	NULL
,	NULL
which	NULL
was	NULL
equivalent	NULL
to	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
for	NULL
wild-type	NULL
HIV-1	NULL
of	NULL
approximately	NULL
0.1	NULL
to	NULL
0.5	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infective	NULL
dose	NULL
per	NULL
cell	NULL
)	NULL
.	NULL

Suspensions	NULL
of	NULL
10°	NULL
cells	NULL
and	NULL
virus	NULL
inocula	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
h	NULL
and	NULL
then	NULL
briefly	NULL
trypsinized	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
fed	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
in	NULL
T-25	NULL
flasks	NULL
,	NULL
and	NULL
cell-free	NULL
supernatant	NULL
was	NULL
sampled	NULL
for	NULL
an	NULL
initial	NULL
time	NULL
point	NULL
.	NULL

Viral	NULL
replication	NULL
was	NULL
monitored	NULL
by	NULL
sampling	NULL
the	NULL
supernatant	NULL
every	NULL
3	NULL
to	NULL
4	NULL
days	NULL
thereafter	NULL
and	NULL
replacing	NULL
with	NULL
fresh	NULL
medium	NULL
or	NULL
expanding	NULL
cultures	NULL
as	NULL
necessary	NULL
.	NULL

Superna-tants	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
and	NULL
subsequently	NULL
assayed	NULL
for	NULL
concentration	NULL
.	NULL

Each	NULL
datum	NULL
point	NULL
represents	NULL
the	NULL
mean	NULL
for	NULL
duplicate	NULL
infections	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Infection	NULL
of	NULL
PBL	NULL
s	NULL
stimulated	NULL
with	NULL
phytohemaggluti-nin	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
maintained	NULL
in	NULL
interleukin-2	NULL
(	NULL
600	NULL
U	NULL
per	NULL
mi	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Corporation	NULL
,	NULL
Indianapolis	NULL
,	NULL
Ind	NULL
.	NULL
)	NULL

(	NULL
1	NULL
)	NULL
;	NULL
(	NULL
B	NULL
)	NULL
infection	NULL
of	NULL
11.8	NULL
cells	NULL
(	NULL
a	NULL
stable	NULL
hybrid	NULL
of	NULL
DF	NULL
and	NULL
Molt-4	NULL
human	NULL
T-cell	NULL
lines	NULL
[	NULL
9	NULL
]	NULL
)	NULL
;	NULL
(	NULL
C	NULL
)	NULL
infection	NULL
of	NULL
CEMx174	NULL
cells	NULL
,	NULL
a	NULL
T-cell-B-cell	NULL
hybrid	NULL
(	NULL
17	NULL
)	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

postinfection	NULL
(	NULL
p.i	NULL
.	NULL
)	NULL

in	NULL
PBL	NULL
s	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
and	NULL
10°	NULL
ng/ml	NULL
48	NULL
days	NULL
p.i	NULL
.	NULL

in	NULL
11.8	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
behavior	NULL
of	NULL
mutant	NULL
-183/	NULL
-166	NULL
NXS	NULL
was	NULL
closest	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
virus	NULL
but	NULL
demonstrated	NULL
slower	NULL
kinetics	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
occasionally	NULL
produced	NULL
lower	NULL
concentrations	NULL
of	NULL
viral	NULL
antigen	NULL
.	NULL

In	NULL
PBL	NULL
infections	NULL
,	NULL
~183/-166	NULL
NXS	NULL
yielded	NULL
to	NULL
10	NULL
ng	NULL
of	NULL
p24®°°=	NULL
per	NULL
ml	NULL
10	NULL
days	NULL
p.i	NULL
.	NULL

and	NULL
10°	NULL
ng	NULL
of	NULL
per	NULL
ml	NULL
50	NULL
days	NULL
p.i	NULL
.	NULL

in	NULL
11.8	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

None	NULL
of	NULL
the	NULL
other	NULL
mutant	NULL
viruses	NULL
produced	NULL
significant	NULL
levels	NULL
of	NULL
p24°	NULL
``	NULL
~	NULL
in	NULL
either	NULL
of	NULL
these	NULL
differentiated	NULL
T-cell	NULL
types	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
the	NULL
cell	NULL
line	NULL
used	NULL
to	NULL
raise	NULL
viral	NULL
stocks	NULL
in	NULL
cocultures	NULL
,	NULL
CEMx174	NULL
,	NULL
demonstrated	NULL
the	NULL
greatest	NULL
permissiveness	NULL
for	NULL
virus	NULL
replication	NULL
in	NULL
single-cell-type	NULL
mfectxons	NULL
,	NULL
achieving	NULL
p24®	NULL
``	NULL
``	NULL
levels	NULL
of	NULL
10°	NULL
ng/ml	NULL
by	NULL
12	NULL
days	NULL
p.i	NULL
.	NULL

for	NULL
both	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
-183/-166	NULL
NXS	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

CEMx174	NULL
was	NULL
the	NULL
only	NULL
cell	NULL
line	NULL
in	NULL
which	NULL
mutant	NULL
viruses	NULL
-147/-130	NULL
NXS	NULL
,	NULL
-165/-148	NULL
NXS	NULL
,	NULL
and	NULL
-201/-184	NULL
NXS	NULL
replicated	NULL
in	NULL
sufficient	NULL
amounts	NULL
to	NULL
detect	NULL
antigen	NULL
in	NULL
the	NULL
supernatant	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Mutants	NULL
-93/-76	NULL
NXS	NULL
and	NULL
-75/	NULL
-58	NULL
NXS	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
any	NULL
of	NULL
the	NULL
individual-cell-type	NULL
infections	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
of	NULL
reversion	NULL
to	NULL
a	NULL
wild-type	NULL
phenotype	NULL
as	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
growth	NULL
of	NULL
-183/-166	NULL
NXS	NULL
and	NULL
for	NULL
the	NULL
observed	NULL
delayed	NULL
kinetics	NULL
in	NULL
CEMx174	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
infections	NULL
with	NULL
mutants	NULL
-165/-148	NULL
NXS	NULL
,	NULL
-147/-130	NULL
NXS	NULL
,	NULL
and	NULL
-201/-184	NULL
NXS	NULL
,	NULL
reinfections	NULL
of	NULL
CEMx174	NULL
were	NULL
performed	NULL
with	NULL
mutant	NULL
virus	NULL
stocks	NULL
obtained	NULL
late	NULL
in	NULL
productive	NULL
infections	NULL
of	NULL
CEMx174	NULL
cells	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
up	NULL
to	NULL
60	NULL
days	NULL
p.i	NULL
.	NULL
)	NULL

.	NULL

These	NULL
reinfections	NULL
yielded	NULL
replication	NULL
kinetics	NULL
indistinguishable	NULL
from	NULL
those	NULL
of	NULL
infections	NULL
with	NULL
the	NULL
parental	NULL
mutant	NULL
stocks	NULL
,	NULL
supporting	NULL
the	NULL
validity	NULL
of	NULL
the	NULL
initial	NULL
observations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
ensure	NULL
that	NULL
each	NULL
mutant	NULL
virus	NULL
was	NULL
capable	NULL
of	NULL
entry	NULL
and	NULL
reverse	NULL
transcription	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
was	NULL
performed	NULL
on	NULL
DNA	NULL
samples	NULL
obtained	NULL
from	NULL
cells	NULL
infected	NULL
with	NULL
DNase	NULL
I-treated	NULL
virus	NULL
stocks	NULL
.	NULL

We	NULL
extracted	NULL
high-molecular-weight	NULL
nuclear	NULL
DNA	NULL
from	NULL
10°	NULL
PBLs	NULL
at	NULL
3	NULL
and	NULL
30	NULL
days	NULL
p.i	NULL
.	NULL

and	NULL
amplified	NULL
an	NULL
HIV-1-specific	NULL
115-bp	NULL
target	NULL
gag	NULL
sequence	NULL
using	NULL
commercial	NULL
oligonucleotide	NULL
primers	NULL
[	NULL
SK38	NULL
(	NULL
1551/1578	NULL
)	NULL
;	NULL
Perkin-Elmer	NULL
Corporation	NULL
,	NULL
Norwalk	NULL
,	NULL
Conn.	NULL
]	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
HIV-1	NULL
sequences	NULL
in	NULL
each	NULL
sample	NULL
,	NULL
detected	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
in	NULL
agarose	NULL
gels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirmed	NULL
that	NULL
the	NULL
observed	NULL
phenotypes	NULL
of	NULL
mutant	NULL
viruses	NULL
were	NULL
due	NULL
neither	NULL
to	NULL
an	NULL
inability	NULL
to	NULL
infect	NULL
the	NULL
target	NULL
cells	NULL
nor	NULL
to	NULL
defects	NULL
in	NULL
viral	NULL
entry	NULL
and	NULL
integration	NULL
.	NULL

Infected	NULL
cell	NULL
DNA	NULL
preparations	NULL
were	NULL
also	NULL
analyzed	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
using	NULL
a	NULL
primer	NULL
pair	NULL
that	NULL
amplified	NULL
577	NULL
bp	NULL
of	NULL
the	NULL
LTR	NULL
sequence	NULL
(	NULL
-439	NULL
to	NULL
+138	NULL
)	NULL
.	NULL

Each	NULL
mutant	NULL
LTR	NULL
fragment	NULL
was	NULL
sequenced	NULL
,	NULL
confirming	NULL
not	NULL
only	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NXS	NULL
linkers	NULL
but	NULL
also	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
additional	NULL
potentially	NULL
compensatory	NULL
LTR	NULL
mutations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
growth	NULL
characteristics	NULL
in	NULL
PBLs	NULL
and	NULL
11.8	NULL
and	NULL
CEMx174	NULL
cells	NULL
,	NULL
the	NULL
six	NULL
mutant	NULL
viruses	NULL
were	NULL
classified	NULL
into	NULL
three	NULL
broad	NULL
phenotypes	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Wild-type	NULL
replication	NULL
phenotype	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

Mutant	NULL
-183/-166	NULL
NXS	NULL
consistently	NULL
demonstrated	NULL
a	NULL
replication	NULL
phenotype	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
mutant	NULL
linker	NULL
substitutes	NULL
8	NULL
bp	NULL
of	NULL
the	NULL
possible	NULL
upstream	NULL
repression	NULL
sequence	NULL
(	NULL
URS	NULL
)	NULL
(	NULL
-188	NULL
to	NULL
-176	NULL
)	NULL
and	NULL
8	NULL
bp	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
1	NULL
(	NULL
USF-1	NULL
)	NULL
(	NULL
-173	NULL
to	NULL
-~160	NULL
)	NULL
,	NULL
a	NULL
putative	NULL
negative	NULL
regulatory	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
2	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
mutations	NULL
in	NULL
nucleotides	NULL
-183	NULL
to	NULL
-166	NULL
alone	NULL
do	NULL
not	NULL
produce	NULL
a	NULL
phenotype	NULL
indicative	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
for	NULL
this	NULL
region	NULL
.	NULL

These	NULL
infection	NULL
results	NULL
contrast	NULL
with	NULL
our	NULL
previously	NULL
reported	NULL
transfection	NULL
experiments	NULL
with	NULL
Jurkat	NULL
cells	NULL
.	NULL

In	NULL
those	NULL
experiments	NULL
,	NULL
moderately	NULL
decreased	NULL
LTR-CAT	NULL
expression	NULL
(	NULL
42	NULL
%	NULL
of	NULL
that	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
observed	NULL
(	NULL
23	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Severely	NULL
reduced	NULL
replication	NULL
phenotype	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

Linker	NULL
substitution	NULL
mutation	NULL
of	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
caused	NULL
drastic	NULL
diminution	NULL
of	NULL
viral	NULL
replication	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Mutant	NULL
-93/-76	NULL
NXS	NULL
substitutes	NULL
the	NULL
entire	NULL
3'-proximal	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
,	NULL
NF-	NULL
«	NULL
B-I	NULL
(	NULL
-91	NULL
to	NULL
-81	NULL
)	NULL
,	NULL
and	NULL
3	NULL
bp	NULL
of	NULL
the	NULL
5'-proximal	NULL
Spl-binding	NULL
site	NULL
,	NULL
Spl-III	NULL
(	NULL
-78	NULL
to	NULL
-67	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Mutant	NULL
-75/-58	NULL
NXS	NULL
replaces	NULL
most	NULL
of	NULL
both	NULL
the	NULL
5'-proximal	NULL
(	NULL
Sp1-III	NULL
[	NULL
-78	NULL
to	NULL
-67	NULL
]	NULL
)	NULL
and	NULL
the	NULL
middle	NULL
(	NULL
Spl-II	NULL
[	NULL
-66	NULL
to	NULL
-57	NULL
]	NULL
)	NULL
Spl-binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Their	NULL
dramatic	NULL
effects	NULL
in	NULL
viral	NULL
infections	NULL
agree	NULL
with	NULL
our	NULL
previous	NULL
transfection	NULL
analysis	NULL
,	NULL
in	NULL
which	NULL
these	NULL
mutations	NULL
had	NULL
the	NULL
greatest	NULL
effects	NULL
on	NULL
LTR-CAT	NULL
expression	NULL
,	NULL
resulting	NULL
in	NULL
as	NULL
little	NULL
as	NULL
4	NULL
and	NULL
21	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
expression	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
illustrate	NULL
the	NULL
absolute	NULL
requirement	NULL
of	NULL
these	NULL
cis-acting	NULL
elements	NULL
for	NULL
efficient	NULL
viral	NULL
replication	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Severely	NULL
reduced	NULL
replication	NULL
phenotype	NULL
in	NULL
PBLs	NULL
and	NULL
11.8	NULL
cells	NULL
but	NULL
delayed	NULL
replication	NULL
kinetics	NULL
in	NULL
CEMx174	NULL
.	NULL

Although	NULL
PBLs	NULL
and	NULL
11.8	NULL
cells	NULL
failed	NULL
to	NULL
support	NULL
infections	NULL
with	NULL
viruses	NULL
-201/-184	NULL
NXS	NULL
,	NULL
-165/-148	NULL
NXS	NULL
,	NULL
and	NULL
-147/-130	NULL
NXS	NULL
,	NULL
these	NULL
viruses	NULL
replicated	NULL
successfully	NULL
in	NULL
the	NULL
highly	NULL
permissive	NULL
CEMx174	NULL
cells	NULL
,	NULL
both	NULL
in	NULL
the	NULL
initial	NULL
transfection	NULL
NOTES	NULL
1661	NULL
cocultivation	NULL
and	NULL
in	NULL
the	NULL
subsequent	NULL
individual-cell-type	NULL
infections	NULL
at	NULL
lower	NULL
multiplicities	NULL
of	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Since	NULL
no	NULL
significant	NULL
replication	NULL
of	NULL
these	NULL
mutants	NULL
in	NULL
either	NULL
PBL	NULL
s	NULL
or	NULL
the	NULL
11.8	NULL
cells	NULL
was	NULL
observed	NULL
,	NULL
the	NULL
substituted	NULL
regions	NULL
appear	NULL
necessary	NULL
for	NULL
growth	NULL
in	NULL
these	NULL
differentiated	NULL
T-cell	NULL
types	NULL
.	NULL

The	NULL
regions	NULL
altered	NULL
by	NULL
these	NULL
mutants	NULL
are	NULL
poorly	NULL
characterized	NULL
with	NULL
respect	NULL
to	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Mutant	NULL
-165/	NULL
-148	NULL
NXS	NULL
contains	NULL
a	NULL
substitution	NULL
of	NULL
the	NULL
downstream	NULL
6	NULL
bp	NULL
of	NULL
the	NULL
USF-1-binding	NULL
site	NULL
and	NULL
exhibited	NULL
delayed	NULL
kinetics	NULL
in	NULL
CEMx174	NULL
infection	NULL
but	NULL
produced	NULL
levels	NULL
of	NULL
p24	NULL
(	NULL
10°	NULL
ng/ml	NULL
)	NULL
close	NULL
to	NULL
those	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
by	NULL
42	NULL
days	NULL
p.i	NULL
.	NULL

Virus	NULL
-201/-184	NULL
NXS	NULL
also	NULL
produced	NULL
wild-type	NULL
concentrations	NULL
of	NULL
25	NULL
days	NULL
p.i	NULL
.	NULL

,	NULL
despite	NULL
the	NULL
substitution	NULL
of	NULL
potential	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
NRE	NULL
)	NULL
sequences	NULL
.	NULL

Mutant	NULL
-147/-130	NULL
NXS	NULL
substitutes	NULL
10	NULL
bp	NULL
of	NULL
the	NULL
T-cell	NULL
factor	NULL
la-lymphoid	NULL
enhancer-binding	NULL
factor	NULL
1	NULL
(	NULL
TCF-1o/LEF-1	NULL
)	NULL
-binding	NULL
site	NULL
(	NULL
-139	NULL
to	NULL
-124	NULL
)	NULL
and	NULL
,	NULL
like	NULL
mutant	NULL
-165/-148	NULL
NXS	NULL
,	NULL
attained	NULL
p24®	NULL
``	NULL
®	NULL
levels	NULL
of	NULL
10°	NULL
ng/ml	NULL
40	NULL
days	NULL
p.i	NULL
.	NULL

in	NULL
CEMx174	NULL
infections	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Transcription	NULL
factor-binding	NULL
sites	NULL
affected	NULL
by	NULL
the	NULL
linker	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

(	NULL
i	NULL
)	NULL
NF-sB	NULL
and	NULL
Sp1	NULL
.	NULL

Our	NULL
results	NULL
establish	NULL
the	NULL
absolute	NULL
requirement	NULL
of	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
for	NULL
viral	NULL
replication	NULL
under	NULL
the	NULL
conditions	NULL
examined	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
reports	NULL
that	NULL
conclude	NULL
that	NULL
Sp1	NULL
sites	NULL
are	NULL
critical	NULL
for	NULL
HIV-1	NULL
replication	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
but	NULL
contrast	NULL
with	NULL
observations	NULL
that	NULL
intact	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
,	NULL
in	NULL
various	NULL
combina-tions	NULL
,	NULL
were	NULL
dispensable	NULL
for	NULL
viral	NULL
replication	NULL
under	NULL
certain	NULL
conditions	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
results	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
activities	NULL
under	NULL
the	NULL
different	NULL
conditions	NULL
and	NULL
with	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
examined	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
USF-1	NULL
and	NULL
URS	NULL
.	NULL

All	NULL
three	NULL
cell	NULL
types	NULL
were	NULL
permissive	NULL
for	NULL
replication	NULL
of	NULL
-183/-166	NULL
NXS	NULL
,	NULL
with	NULL
little	NULL
difference	NULL
in	NULL
kinetics	NULL
or	NULL
output	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
.	NULL

As	NULL
noted	NULL
above	NULL
,	NULL
this	NULL
contrasts	NULL
with	NULL
our	NULL
earlier	NULL
transfection	NULL
findings	NULL
and	NULL
does	NULL
not	NULL
support	NULL
the	NULL
role	NULL
of	NULL
USF-1	NULL
in	NULL
negative	NULL
regulatory	NULL
activity	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
linker	NULL
substitution	NULL
in	NULL
mutant	NULL
-201/	NULL
-184	NULL
NXS	NULL
replaces	NULL
sequences	NULL
between	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
-binding	NULL
site	NULL
and	NULL
the	NULL
URS	NULL
,	NULL
previously	NULL
suggested	NULL
to	NULL
possess	NULL
negative	NULL
regulatory	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
putative	NULL
NRE	NULL
might	NULL
be	NULL
expected	NULL
to	NULL
have	NULL
either	NULL
no	NULL
effect	NULL
or	NULL
increased	NULL
replication	NULL
kinetics	NULL
.	NULL

Mutant	NULL
-201/-184	NULL
NXS	NULL
replicated	NULL
only	NULL
in	NULL
CEMx174	NULL
cells	NULL
and	NULL
with	NULL
delayed	NULL
kinetics	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
sequences	NULL
from	NULL
-201	NULL
to	NULL
-184	NULL
have	NULL
a	NULL
positive	NULL
rather	NULL
than	NULL
negative	NULL
regulatory	NULL
function	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
TCF-1o	NULL
@	NULL
/LEF-1	NULL
.	NULL

Another	NULL
mutant	NULL
virus	NULL
which	NULL
replicated	NULL
only	NULL
in	NULL
CEMx174	NULL
cells	NULL
,	NULL
-147/-130	NULL
NXS	NULL
,	NULL
contains	NULL
a	NULL
substitution	NULL
of	NULL
the	NULL
5'-most	NULL
10	NULL
bp	NULL
of	NULL
the	NULL
TCF-1o/LEF-1-binding	NULL
site	NULL
.	NULL

Its	NULL
delayed	NULL
growth	NULL
rate	NULL
in	NULL
CEMx174	NULL
cells	NULL
and	NULL
its	NULL
inability	NULL
to	NULL
replicate	NULL
in	NULL
PBLs	NULL
and	NULL
11.8	NULL
cells	NULL
suggest	NULL
that	NULL
this	NULL
binding	NULL
site	NULL
may	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
viral	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

TCF-1	NULL
«	NULL
/LEF-1	NULL
is	NULL
a	NULL
thymus-	NULL
and	NULL
lymphocyte-specific	NULL
factor	NULL
which	NULL
activates	NULL
transcription	NULL
via	NULL
binding	NULL
to	NULL
its	NULL
pyrimidine-rich	NULL
target	NULL
sequence	NULL
(	NULL
6	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Its	NULL
transcriptional	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
dependent	NULL
upon	NULL
the	NULL
sequence	NULL
context	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
negative	NULL
effects	NULL
of	NULL
linker	NULL
substitution	NULL
mutations	NULL
surrounding	NULL
the	NULL
-147/-130	NULL
NXS	NULL
mutation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Summary	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
transient-transfection	NULL
analysis	NULL
using	NULL
T-cell	NULL
lines	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
linker	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
LTR	NULL
region	NULL
between	NULL
-201	NULL
and	NULL
-130	NULL
lowered	NULL
transcription	NULL
to	NULL
between	NULL
25	NULL
and	NULL
75	NULL
%	NULL
of	NULL
that	NULL
for	NULL
the	NULL
wild-type	NULL
LTR	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
position	NULL
of	NULL
the	NULL
linker	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
LTR	NULL
sequences	NULL
had	NULL
not	NULL
been	NULL
previously	NULL
associated	NULL
with	NULL
transcriptional	NULL
activity	NULL
.	NULL

By	NULL
incorporating	NULL
these	NULL
LTRs	NULL
1662	NULL
NOTES	NULL
into	NULL
proviruses	NULL
,	NULL
we	NULL
have	NULL
obtained	NULL
results	NULL
indicating	NULL
that	NULL
infections	NULL
with	NULL
mutant	NULL
virus	NULL
stocks	NULL
demonstrate	NULL
a	NULL
different	NULL
,	NULL
possibly	NULL
more	NULL
accurate	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
linker	NULL
substitution	NULL
mutations	NULL
.	NULL

For	NULL
example	NULL
,	NULL
mutants	NULL
-147/-130	NULL
NXS	NULL
and	NULL
-165/-148	NULL
NXS	NULL
demonstrated	NULL
effects	NULL
on	NULL
viral	NULL
replication	NULL
that	NULL
were	NULL
more	NULL
severe	NULL
than	NULL
the	NULL
effects	NULL
predicted	NULL
by	NULL
their	NULL
transfection	NULL
results	NULL
,	NULL
whereas	NULL
the	NULL
effect	NULL
of	NULL
mutant	NULL
-183/-166	NULL
NXS	NULL
was	NULL
less	NULL
severe	NULL
than	NULL
expected	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
that	NULL
the	NULL
replication	NULL
phenotype	NULL
of	NULL
linker	NULL
substitution	NULL
mutant	NULL
viruses	NULL
depended	NULL
on	NULL
the	NULL
host	NULL
cell	NULL
type	NULL
infected	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
more	NULL
differentiated	NULL
T-cell	NULL
types	NULL
,	NULL
PBLs	NULL
and	NULL
11.8	NULL
cells	NULL
,	NULL
were	NULL
much	NULL
less	NULL
permissive	NULL
for	NULL
replication	NULL
of	NULL
the	NULL
mutant	NULL
viruses	NULL
than	NULL
CEMx174	NULL
cells	NULL
were	NULL
(	NULL
CEMx174	NULL
cells	NULL
>	NULL
11.8	NULL
cells	NULL
=	NULL
PBLs	NULL
)	NULL
.	NULL

This	NULL
hierarchy	NULL
of	NULL
cell	NULL
type	NULL
dependence	NULL
of	NULL
viral	NULL
replication	NULL
suggests	NULL
that	NULL
the	NULL
HIV-1	NULL
LTR	NULL
may	NULL
influence	NULL
cell	NULL
tropism	NULL
and	NULL
that	NULL
some	NULL
cell	NULL
types	NULL
are	NULL
more	NULL
permissive	NULL
for	NULL
LTR	NULL
utilization	NULL
.	NULL

We	NULL
thank	NULL
Indira	NULL
Prabakaran	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
James	NULL
Hoxie	NULL
and	NULL
Glen	NULL
Gaulton	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

J.Y.H.K	NULL
.	NULL

is	NULL
a	NULL
trainee	NULL
in	NULL
the	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
and	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
training	NULL
grant	NULL
NS-07180	NULL
.	NULL

S.L.Z	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
an	NULL
NIH	NULL
Clinical	NULL
Investigator	NULL
award	NULL
and	NULL
was	NULL
an	NULL
AmFAR/Pediatric	NULL
AIDS	NULL
Foundation	NULL
Scholar	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
NS27405	NULL
,	NULL
NS31067	NULL
(	NULL
both	NULL
to	NULL
F.G.-S.	NULL
)	NULL
,	NULL
and	NULL
CA28379	NULL
(	NULL
to	NULL
J.C	NULL
.	NULL

A	NULL
.	NULL
)	NULL

.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Collman	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
N.	NULL
F.	NULL
Hassan	NULL
,	NULL
R.	NULL
Walker	NULL
,	NULL
B.	NULL
Godfrey	NULL
,	NULL
J.	NULL
Cutilli	NULL
,	NULL
J.	NULL
C.	NULL
Hastings	NULL
,	NULL
H.	NULL
Friedman	NULL
,	NULL
S.	NULL
D.	NULL
Douglas	NULL
,	NULL
and	NULL
N.	NULL
Nathanson	NULL
.	NULL

1989	NULL
.	NULL

Infection	NULL
of	NULL
monocyte-derived	NULL
macrophages	NULL
with	NULL
HIV-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:1149-1163	NULL
.	NULL

2	NULL
.	NULL

Garcia	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1987	NULL
.	NULL

Interactions	NULL
of	NULL
cellular	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3761-3770	NULL
.	NULL

3	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

AIDS	NULL
6:347-363	NULL
.	NULL

4	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T-lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4417-4423	NULL
.	NULL

5	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
F.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
J.	NULL
Gonzalez	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1989	NULL
.	NULL

Role	NULL
of	NULL
SP1-binding	NULL
domains	NULL
in	NULL
in	NULL
vivo	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2585-2591	NULL
.	NULL

6	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
L.	NULL
H.	NULL
Yang	NULL
,	NULL
G.	NULL
Morle	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
Ca	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6714-6718	NULL
.	NULL

7	NULL
.	NULL

Hoxie	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
B.	NULL
S.	NULL
Haggarty	NULL
,	NULL
S.	NULL
E.	NULL
Bonser	NULL
,	NULL
J.	NULL
L.	NULL
Rackowski	NULL
,	NULL
H.	NULL
Shan	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Kanki	NULL
.	NULL

1988	NULL
.	NULL

Biological	NULL
characterization	NULL
of	NULL
a	NULL
simian	NULL
immunodeficiency	NULL
virus-like	NULL
retrovirus	NULL
(	NULL
HTLV-IV	NULL
)	NULL
:	NULL
evidence	NULL
for	NULL
CD4-associated	NULL
molecules	NULL
required	NULL
for	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:2557-2568	NULL
.	NULL

8	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
promoter	NULL
by	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
.	NULL

Science	NULL
232:755-759	NULL
.	NULL

9	NULL
.	NULL

Kozbor	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
A.	NULL
Cassatella	NULL
,	NULL
S.	NULL
Lessin	NULL
,	NULL
J.	NULL
Kagan	NULL
,	NULL
S.	NULL
Finver	NULL
,	NULL
J.	NULL
Faust	NULL
,	NULL
G.	NULL
Trinchieri	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Croce	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
and	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

function	NULL
of	NULL
y5-	NULL
and	NULL
«	NULL
B-T	NULL
cell	NULL
receptor	NULL
heterodimers	NULL
on	NULL
human	NULL
somatic	NULL
T	NULL
cell	NULL
hybrids	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3677-3683	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Parrott	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Effects	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
mutations	NULL
on	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4115-4119	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Touzjian	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
T.	NULL
Dorfman	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
repressive	NULL
sequences	NULL
within	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:5226-5229	NULL
.	NULL

Muesing	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
D.	NULL
H.	NULL
Smith	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Capon	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
mRNA	NULL
accumulation	NULL
by	NULL
an	NULL
HIV	NULL
frans-activation	NULL
protein	NULL
.	NULL

Cell	NULL
48:691-701	NULL
.	NULL

Parrott	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Seidner	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
J.	NULL
Leonard	NULL
,	NULL
T.	NULL
S.	NULL
Theodore	NULL
,	NULL
A.	NULL
Buckler-White	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1991	NULL
.	NULL

Variable	NULL
role	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
Spl-binding	NULL
sites	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:1414-1419	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
location	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
HTLV-II/	NULL
LAV	NULL
LTR	NULL
.	NULL

Cell	NULL
41:813-823	NULL
.	NULL

Ross	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
G.	NULL
Englund	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1991	NULL
.	NULL

Contribution	NULL
of	NULL
NF-kB	NULL
and	NULL
Spl	NULL
binding	NULL
motifs	NULL
to	NULL
the	NULL
replicative	NULL
capacity	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
distinct	NULL
patterns	NULL
of	NULL
viral	NULL
growth	NULL
are	NULL
determined	NULL
by	NULL
T-cell	NULL
types	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4350-4358	NULL
.	NULL

Salter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
D.	NULL
N.	NULL
Howell	NULL
,	NULL
and	NULL
P.	NULL
Cresswell	NULL
.	NULL

1985	NULL
.	NULL

Genes	NULL
regulating	NULL
HLA	NULL
class	NULL
I	NULL
antigen	NULL
expression	NULL
in	NULL
T-B	NULL
lymphoblast	NULL
hybrids	NULL
.	NULL

Immunogenetics	NULL
21:235-246	NULL
.	NULL

Srinivasan	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
York	NULL
,	NULL
R.	NULL
Jannoun-Nasr	NULL
,	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
D.	NULL
Swan	NULL
,	NULL
J.	NULL
Benson	NULL
,	NULL
C.	NULL
Bohan	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
S.	NULL
Schnoll	NULL
,	NULL
R.	NULL
A.	NULL
Robinson	NULL
,	NULL
S.	NULL
M.	NULL
Desai	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Devare	NULL
.	NULL

1989	NULL
.	NULL

Generation	NULL
of	NULL
hybrid	NULL
HIV	NULL
by	NULL
homologous	NULL
recombination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6388-6392	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Amsterdam	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1991	NULL
.	NULL

LEF-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
lymphoid-specific	NULL
protein	NULL
,	NULL
with	NULL
an	NULL
HMG	NULL
domain	NULL
,	NULL
regulates	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
function	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:880-894	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
Ca	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:656-669	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
TCF-la	NULL
,	NULL
a	NULL
T-cell-specified	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
T-cell	NULL
receptor	NULL
Ca	NULL
gene	NULL
enhancer	NULL
in	NULL
a	NULL
context-dependent	NULL
man-ner	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:621-636	NULL
.	NULL

Zeichner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
G.	NULL
Hirka	NULL
,	NULL
P.	NULL
W.	NULL
Andrews	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
.	NULL

1992	NULL
.	NULL

Differentiation-dependent	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
regulatory	NULL
elements	NULL
active	NULL
in	NULL
human	NULL
ter-atocarcinoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:2268-2273	NULL
.	NULL

Zeichner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
Y.	NULL
H.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
.	NULL

1991	NULL
.	NULL

Linker-scanning	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2436-2444	NULL
.	NULL

Zeichner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
Y.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
.	NULL

1991	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
competition	NULL
and	NULL
linker	NULL
scanning	NULL
mutagenesis	NULL
.	NULL

Gene	NULL
Expression	NULL
1:15-27	NULL
.	NULL

